Overview Icagen, Inc.

Navigate Icagen, Inc. In silico Drug Discovery. Leading the Way in Drug Discovery Services for Ion Channel and Transporters through First in Class Expertise and Unmatched Capabilities. Icagen Announces Collaboration With Bayer To Develop Novel XRpro Assays. Mar 28, 2017. Icagen announces distribution agreement with On Target for advancing early drug discovery in Japanese market. Jan 10, 2017. View All Press Releases. June 19 - June 22, 2017. Ion Channel Retreat 2017. August 14 - August 16, 2017. Mark Kor.

OVERVIEW

This web site ir.icagen.com presently has a traffic classification of zero (the lower the superior). We have sifted nineteen pages inside the website ir.icagen.com and found one website referencing ir.icagen.com. I noted two mass web platforms linked to ir.icagen.com.
Pages Analyzed
19
Links to this site
1
Social Links
2

IR.ICAGEN.COM RANKINGS

This web site ir.icagen.com is seeing alternating levels of traffic within the past the year.
Traffic for ir.icagen.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for ir.icagen.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for ir.icagen.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO WEB PAGE

Icagen, Inc.

Challenge, Discover, Solve, Lead. Exploration and optimization of chemical series to ensure fast progression, and continual enhancement of our chemical estate of small molecules. Broad range of fully integrated drug discovery activities from target identification to lead generation and beyond.

WHAT DOES IR.ICAGEN.COM LOOK LIKE?

Desktop Screenshot of ir.icagen.com Mobile Screenshot of ir.icagen.com Tablet Screenshot of ir.icagen.com

IR.ICAGEN.COM HOST

Our web crawlers diagnosed that the main root page on ir.icagen.com took four hundred and twenty-two milliseconds to come up. We could not discover a SSL certificate, so in conclusion I consider ir.icagen.com not secure.
Load time
0.422 seconds
SSL
NOT SECURE
Internet Address
52.9.169.65

SERVER OPERATING SYSTEM AND ENCODING

I revealed that this domain is implementing the Apache os.

PAGE TITLE

Overview Icagen, Inc.

DESCRIPTION

Navigate Icagen, Inc. In silico Drug Discovery. Leading the Way in Drug Discovery Services for Ion Channel and Transporters through First in Class Expertise and Unmatched Capabilities. Icagen Announces Collaboration With Bayer To Develop Novel XRpro Assays. Mar 28, 2017. Icagen announces distribution agreement with On Target for advancing early drug discovery in Japanese market. Jan 10, 2017. View All Press Releases. June 19 - June 22, 2017. Ion Channel Retreat 2017. August 14 - August 16, 2017. Mark Kor.

CONTENT

This web site states the following, "Leading the Way in Drug Discovery Services for Ion Channel and Transporters through First in Class Expertise and Unmatched Capabilities." Our analyzers noticed that the web page stated " Icagen Announces Collaboration With Bayer To Develop Novel XRpro Assays." The Website also said " Icagen announces distribution agreement with On Target for advancing early drug discovery in Japanese market. June 19 - June 22, 2017. August 14 - August 16, 2017."

VIEW SIMILAR WEB SITES

株式会社市進ホールディングス IR情報

市進教育グループのシンボル ウイングマーク は Wings for Victory つまり.

Investor Relations ICU Medical

ICU Medical MedNet Safety Software. Hazardous Drug Closed Systems and CSTDs. Cardiac Output Monitoring Sensors and Catheters. Closed Blood Sampling and Conservation. Accurate, Safe, and Efficient Drug Compounding. Less Waste, Lower Cost. Cost-Effectively Comply With USP800 CSTD Guidelines. Enhance Surgical Recovery by Optimizing Fluid Balance.

Home Academic Research Repository at the Institute of Developing Economies,JapanARRIDE

You can read the full text of articles written by IDE researchers.

Investors and Media Investor Relations Idera Pharmaceuticals

Idera to Present at the 2015 Wedbush PacGrow Healthcare Conference.